Pheno Therapeutics granted trial authorisation for MS candidate - PharmaTimes First-in-human trial of PTD802 to commence following UK MHRA approval

#PhenoTherapeutics #Firstinhumantrial #PTD802 #clinicaltrialauthorisation #CTA #smallmoleculetherapeutic #remyelination #multiplesclerosis #MS #neurology #selectiveGPR17antagonist #UCB #Demyelination #DemyelinationinMS #GPR17targetingremyelinationtherapeutics
pharmatimes.com/news/pheno-t...